Business · Companies · 3 hrs ago

Teva to hold R&D event in New York on November 11

Teva to hold R&D event in New York on November 11

Teva Pharmaceutical Industries says it will hold an R&D Day in New York City on Wednesday, November 11, 2026.

The event is scheduled to run from 8:30 a.m.

to 12:30 p.m.

Eastern Time.

Teva’s leaders plan to discuss the company’s research and development pipeline, meaning the treatments it is working on.

They will also discuss the pipeline’s potential to create value over the next five years.

The event will cover Teva’s effort to become an innovative biopharma company through its Pivot to Growth strategy.

In-person attendance is limited to invited analysts and institutional investors.

Teva has not provided further details about the event in the announcement.

Sources

Related news